WHWK
Whitehawk Therapeutics Inc NASDAQ Listed Aug 1, 2017$4.11
After hrs
$4.16
-0.00%
Mkt Cap $254.4M
52w Low $1.60
71.7% of range
52w High $5.10
50d MA $4.26
200d MA $3.07
P/E (TTM)
-2.5x
EV/EBITDA
—
P/B
1.9x
Debt/Equity
0.0x
ROE
-15.1%
P/FCF
-2.6x
RSI (14)
50.30
ATR (14)
$0.29
Beta
0.62
50d MA
$4.26
200d MA
$3.07
Avg Volume
492.8K
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.
17383 Sunset Blvd, Suite A250 · Pacific Palisades, CA 90272 · US
Data updated apr 27, 2026 9:21am
· Source: financialmodelingprep.com